BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Psychiatry. Jun 19, 2026; 16(6): 116408
Published online Jun 19, 2026. doi: 10.5498/wjp.v16.i6.116408
Beyond vision: The overlooked burden of depression in glaucoma patients
Matteo Capobianco, Francesco Cappellani, Marieme Khouyyi, Simonetta Gaia Nicolosi, Fabiana D’Esposito, Mutali Musa, Marco Battista, Piero Barboni, Caterina Gagliano, Marco Zeppieri
Matteo Capobianco, Eye Clinic, Policlinico G. Rodolico, University of Catania, Catania 95121, Italy
Matteo Capobianco, Simonetta Gaia Nicolosi, Faculty of Medicine, University of Catania, Catania 95123, Italy
Francesco Cappellani, Fabiana D’Esposito, Caterina Gagliano, Department of Medicine and Surgery, University of Enna “Kore”, Enna 94100, Italy
Francesco Cappellani, Caterina Gagliano, Mediterranean Foundation, “G.B. Morgagni-DS”, Catania 95125, Italy
Marieme Khouyyi, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina 98121, Italy
Fabiana D’Esposito, Imperial College Ophthalmic Research Group Unit, Imperial College, London NW1 5QH, United Kingdom
Mutali Musa, Department of Optometry, University of Benin, Benin 300283, Nigeria
Mutali Musa, Department of Ophthalmology, Africa Eye Laser Center Ltd, Benin 300211, Nigeria
Marco Battista, Piero Barboni, Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan 20132, Italy
Piero Barboni, Studio Oculistico, d’Azeglio, Bologna 40123, Italy
Marco Zeppieri, Department of Ophthalmology, University Hospital of Udine, Udine 33100, Italy
Marco Zeppieri, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste 34127, Italy
Co-corresponding authors: Caterina Gagliano and Marco Zeppieri.
Author contributions: Capobianco M, Khouyyi M, D’Esposito F, Musa M, Gagliano C, and Zeppieri M conceived and designed the study; Khouyyi M, Nicolosi SG, D’Esposito F, Musa M, Battista M, Barboni P, Gagliano C, and Zeppieri M performed the research, drafted the manuscript and assisted in manuscript writing and editing; Zeppieri M made critical revisions of the manuscript and reviewed all versions of the manuscript; Gagliano C and Zeppieri M they contributed equally to this article, they are the co-corresponding authors of this manuscript; and all authors approved the final version of the article.
AI contribution statement: ChatGPT (OpenAI, GPT-5.3) and Grammarly were used to assist with summarizing existing literature, addressing issues in the rebuttal, and enhancing the flow and English language quality. No AI-generated images were used.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Marco Zeppieri, MD, PhD, Consultant, Department of Ophthalmology, University Hospital of Udine, p. le S. Maria della Misericordia 15, Udine 33100, Italy. mark.zeppieri@asufc.sanita.fvg.it
Received: November 11, 2025
Revised: January 5, 2026
Accepted: February 10, 2026
Published online: June 19, 2026
Processing time: 198 Days and 20.5 Hours
Core Tip

Core Tip: Depression is common in people with glaucoma and still too often missed. The slow loss of vision, the fear of blindness, reduced social participation, and the day-to-day burden of complex treatment plans all take a psychological toll and erode quality of life. When depressive symptoms are present, patients are less likely to adhere to medications, sustain self-care, or keep follow-up appointments - behaviors that, in turn, can worsen visual outcomes. Emerging evidence also points to shared biology between glaucoma and depression. Neuroinflammation, mitochondrial dysfunction, and dysregulation of the hypothalamic-pituitary-adrenal axis recurs across both conditions and may help explain their clinical co-occurrence. For these reasons, routine identification and management of depression should be part of glaucoma care: Addressing mental health is not ancillary - it is integral to protecting vision.

Write to the Help Desk